Blueberries Medical Corp. (C:BBM*CA)

Business Focus: Cannabis Product Retailers

Sector:  Consumer Non-Cyclicals Industry:  Drug Retailers
 
Company Contact
Address: 82 Richmond Street East
TORONTO ON M5C 1P1
Tel: N/A
Website: https://www.blueberriesmed.com
IR: See website
<
Key People
N/A    
Business Overview
Blueberries Medical Corp. is a Canada-based company, which is a licensed producer of psychoactive and non-psychoactive cannabis by-products in Colombia. The Company is engaged in the growth, cultivation, and development of medicinal cannabis and related products with operations in Colombia. The Company is focused on processing and supplying medicinal-grade Cannabis oil extracts, medical flowers, and related products. It is developing and commercializing a range of cannabis-derived ingredients, including high and low tetrahydrocannabinol (THC), cannabidiol (CBD), and other cannabinoids. The Company's subsidiaries include Blueberries Research Corporation (BRC), Blueberries SAS (BBSAS), Centro De Desarrollo e Investigacion (CDIBBSAS), BBV Labs Inc. (BBV Labs.) and SATIN S.A.S. (SATIN). Blueberries SAS is a licensed producer and distributor of medicinal Cannabis and Cannabis-derived products in Colombia.
Financial Overview
For the fiscal year ended 31 December 2023, Blueberries Medical Corp revenues increased 22% to C$288K. Net loss increased 11% to C$1.6M. Revenues reflect Colombia segment increase of 4% to C$246K. Higher net loss reflects Changes of fair value of derivative liab decrease of 89% to C$58K (income), Director and management fees increase from C$84K to C$294K (expense). Basic Earnings per Share excluding Extraordinary Items remained flat at -C$0.01.
Reporting Currency: Canadian Dollars
Enterprise value: $5.18M as of Dec 31, 2023
Annual revenue (TTM): $0.29M as of Dec 31, 2023
EBITDA (TTM): -$1.21M as of Dec 31, 2023
Net annual income (TTM): -$1.64M as of Dec 31, 2023
Free cash flow (TTM): -$1.35M as of Dec 31, 2023
Net Debt Last Fiscal Year: N/A
Shares outstanding: 218,309,152 as of Dec 31, 2023
TTM: Trailing Twelve Months
EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization

Thank you for visiting InsiderTracking.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you wish to consider using a browser that blocks ads, please log in or subscribe.

Alternatively, if you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). If you are in private browsing mode and do not want to subscribe, please disable tracking protection while visiting our website.

Thank you for using Insider Tracking.